| BALCX | JABAX | BALCX / JABAX | |
| Total Expense Ratio | 1.31 | 0.82 | 160% |
| Annual Report Gross Expense Ratio | 1.31 | 0.82 | 160% |
| Fund Existence | 25 years | 33 years | - |
| Gain YTD | 13.334 | 12.881 | 104% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 2500 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 263B | 28.5B | 923% |
| Annual Yield % from dividends | 1.10 | 1.58 | 70% |
| Returns for 1 year | 8.17 | 7.27 | 112% |
| Returns for 3 years | 38.17 | 40.37 | 95% |
| Returns for 5 years | 34.58 | 36.85 | 94% |
| Returns for 10 years | 63.59 | 93.83 | 68% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| HELX | 35.66 | 0.67 | +1.92% |
| Franklin Genomic Advancements ETF | |||
| PJFG | 109.24 | 0.76 | +0.70% |
| PGIM Jennison Focused Growth ETF | |||
| SPYI | 51.67 | 0.19 | +0.36% |
| NEOS S&P 500(R) High Income ETF | |||
| SEPU | 28.37 | 0.05 | +0.19% |
| AllianzIM U.S. Equity Buffer15 UncSepETF | |||
| RPAR | 21.25 | -0.02 | -0.11% |
| RPAR Risk Parity ETF | |||